Intuitive Machines CEO Executes $1.4M Stock Sale for Tax Purposes

The Motley FoolThe Motley Fool
|||1 min read
Key Takeaway

Intuitive Machines CEO sold $1.4M in stock for tax purposes. Despite new Air Force contracts, the company remains unprofitable with declining revenue.

Intuitive Machines CEO Executes $1.4M Stock Sale for Tax Purposes

Stephen Altemus, Chief Executive Officer of Intuitive Machines, sold 86,803 shares valued at approximately $1.39 million on February 13, 2026. The transaction was executed to satisfy tax withholding obligations associated with the vesting of restricted stock units, a common practice among corporate executives and not necessarily indicative of broader confidence shifts in the company's outlook.

The aerospace company has achieved notable momentum during 2026, securing new contracts with the U.S. Air Force and benefiting from heightened investor enthusiasm surrounding the commercial space sector. However, the company continues to operate at a loss, with revenue declining year-over-year, raising questions about the sustainability of current market valuations.

Financial analysts point to Intuitive Machines' price-to-sales ratio of nine as a significant valuation concern, particularly given the company's unprofitable status and contracting revenue base. This metric suggests the stock may be overvalued relative to its current financial performance, warranting caution among investors evaluating the company's investment thesis.

Source: The Motley Fool

Back to newsPublished Feb 19

Related Coverage

The Motley Fool

Palantir Crushes Earnings but Valuation Concerns Weigh on Stock

Palantir crushed Q1 earnings with 85% revenue growth, but stock fell 34% from highs due to excessive 67x price-to-sales and 153x P/E valuations.

PLTR
GlobeNewswire Inc.

Arcutis Bolsters Team With $269K RSU Grants as FDA Expands ZORYVE Potential

Arcutis granted 309,000 equity awards to 40 new hires. Company seeks FDA approval to expand ZORYVE cream to treat atopic dermatitis in infants as young as 3 months.

ARQT
GlobeNewswire Inc.

Pacira BioSciences Awards $1.5M in Equity Grants to Attract Top Talent

Pacira BioSciences granted inducement equity awards to 10 new employees, including stock options and RSUs valued at approximately $1.5M, under Nasdaq rules.

PCRX
GlobeNewswire Inc.

Cue Biopharma Awards $30M+ in Equity to New Leadership and Staff

Cue Biopharma grants inducement equity to new President and CEO Dr. Shao-Lee Lin and six employees under Nasdaq rules, signaling leadership transition and growth strategy.

CUE
The Motley Fool

Maze Therapeutics CSBO Sells $190K in Stock Despite Strong Trial Data

Maze Therapeutics CSBO Atul Dandekar sold 7,500 shares for $190,000 under a pre-planned trading agreement, concurrent with positive phase 2 trial results.

MAZE
The Motley Fool

York Space Acquires All.Space: Strategic Bet or Overpriced Gamble?

York Space Systems stock surged 13.4% on All.Space acquisition, though the unprofitable company's 10x sales valuation and undisclosed deal terms raise strategic questions.

YSS